JW (Cayman) Therapeutics Co. Ltd

JWCTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$267,265-$350,357-$240,267-$387,581
Dep. & Amort.$0$42,774$46,889$50,319
Deferred Tax$0$0$0$0
Stock-Based Comp.$4,536$18,752$18,557$3,011
Change in WC$0-$15,597$0$3,188
Other Non-Cash$262,729$159,189-$13,383$170,676
Operating Cash Flow$0-$145,239-$188,204-$160,387
Investing Activities
PP&E Inv.$0-$2,353-$2,869-$5,648
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$128-$10,075-$1,965
Investing Cash Flow$0-$2,481-$12,944-$7,613
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$33,438$57,052-$88,622
Financing Cash Flow$0$33,438$57,052-$88,622
Forex Effect$0$2,623$7,221-$10,362
Net Chg. in Cash$0$0$0$0
Supplemental Information
Beg. Cash$0$0$0$1,272,893
End Cash$0$0$0$1,272,893
Free Cash Flow$0-$147,592-$191,073-$166,035